Clinical Trial Update: Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a three-drug combination of gemcitabine, oxaliplatin, and capecitabine in patients with advanced cholangiocarcinoma. The study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• Xeloda (capecitabine)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Cholangiocarcinoma | Phase 1, Phase 2 | Status: COMPLETED